Camilla Panduro Nielsen,
Ebbe L. Lorenzen,
Kenneth Jensen,
Jesper Grau Eriksen,
Jørgen Johansen,
Niels Gyldenkerne
et al.:
Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines
Radiotherapy and Oncology 2024
DOI
Erlend Skaga,
Cassia Bree Trewin-Nybråten,
Pitt Niehusmann,
Tom Børge Johannessen,
Kirsten Marienhagen,
Leif Oltedal
et al.:
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
Carsten Nieder,
Kirsten Marienhagen,
Roy Morten Kristensen,
Torbjørn Sørbye,
Lars Hoem
:
Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors
Oncology Letters 2016
DOI
Jörn Schulz,
Stein Olav Skrøvseth,
Veronika Kristine Tømmerås,
Kirsten Marienhagen,
Fred Godtliebsen
:
A semiautomatic tool for prostate segmentation in radiotherapy treatment planning
Carsten Nieder,
Kirsten Marienhagen,
Astrid Dalhaug,
Gro Aandahl,
Ellinor Haukland,
Adam Pawinski
:
Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
Medical Oncology (MO) 2014
DOI
Carsten Nieder,
Kirsten Marienhagen,
Astrid Dalhaug,
Gro Aandahl,
Ellinor Haukland,
Adam Pawinski
:
Prognostic models predicting survival of patients with brain metastases: Integration of lactate dehydrogenase, albumin and extracranial organ involvement
Clinical Oncology 2014
DOI
Carsten Nieder,
Kirsten Marienhagen,
Astrid Dalhaug,
Jan Norum
:
Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
Scientific World Journal 2012
ARKIV /
DOI
Carsten Nieder,
Anca L. Grosu,
Kirsten Marienhagen,
Nikolaus H. Andratschke,
Hans Geinitz
:
Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases
Medical Oncology (MO) 2012
DOI
Carsten Nieder,
Kirsten Marienhagen,
Hans Geinitz,
Anca L. Grosu
:
Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?
Journal of Cancer Research and Therapeutics 2011
ARKIV /
DOI
Carsten Nieder,
Sabrina T. Astner,
Nikolaus H. Andratschke,
Kirsten Marienhagen
:
Postoperative treatment and prognosis of patients with resected single brain metastasis: How useful are established prognostic scores?
Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) 2011
DOI
Kirsten Marienhagen,
Åslaug Helland,
Terje Nordberg,
Marianne Grønlie Guren,
Eva Hofsli
:
Hva mener norske onkologer om sin arbeidssituasjon?
Tidsskrift for Den norske legeforening 2010
DOI
Liv Cathrine Heggebø,
Ida Maria Henriksen Borgen,
Hillevi Rylander,
Cecilie E. Kiserud,
Tonje Kristin Haug Nordenmark,
Taran Annette Paulsen Hellebust
et al.:
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
Laura Toussaint,
Petter Brandal,
Anna Embring,
Jacob Engellau,
Morten Egeberg Evensen,
Romualdas Griskeviskius
et al.:
Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
Einar Waldeland,
Olav Dahl,
Odd Harald Odland,
Stein Olav Kvaløy,
Jo-Åsmund Lund,
Eirik Malinen
et al.:
Particle therapy in Norway - report from the national project group
Radiotherapy and Oncology 2014